The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Temsirolimus (T) in patients (pts) with solid tumors with PIK3CA mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
 
Carmen Julia Calfa
No Relationships to Disclose
 
Michael Rothe
No Relationships to Disclose
 
Gordan Srkalovic
Speakers' Bureau - EUSA Pharma; Foundation Medicine; Johnson & Johnson
 
Herbert Leon Duvivier
Speakers' Bureau - AstraZeneca; Guardant Health; Regeneron
 
Deepti Behl
Consulting or Advisory Role - AAA HealthCare; AstraZeneca; Bristol Myers Squibb Foundation; Ipsen; Janssen Oncology; Lilly; Mirati Therapeutics; Novartis; Novocure; Signatera
Speakers' Bureau - AstraZeneca; Janssen Oncology
 
J Michael Straughn
No Relationships to Disclose
 
Kathleen J Yost
Stock and Other Ownership Interests - Pfizer (I)
Research Funding - Pfizer
Other Relationship - AstraZeneca; Natera; Pfizer
 
Inderjit Mehmi
Speakers' Bureau - Bristol-Myers Squibb
 
Evan P. Pisick
No Relationships to Disclose
 
Bhavina B Sharma
No Relationships to Disclose
 
Ramya Thota
No Relationships to Disclose
 
Dan Steven Veljovich
Stock and Other Ownership Interests - Abbvie; Adaptive Biotechnologies; AstraZeneca; Bristol-Myers Squibb/Roche; CVS Health; Gilead Sciences; GlaxoSmithKline; haleon; InVitae; Johnson & Johnson; Medtronic; Merck; Pfizer; Pfizer; Seagen; SPDR S and P Biotech ETF; Teladoc; United Health Group; Veeva Systems
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck; Seagen
 
Olatunji B. Alese
Consulting or Advisory Role - AADi; Bristol-Myers Squibb; Pfizer; QED Therapeutics; Seagen; Seagen; Taiho Oncology
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corcept Therapeutics (Inst); GlaxoSmithKline (Inst); Hutchison MediPharma (Inst); Ipsen (Inst); PCI Biotech (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Transcenta (Inst)
 
Timothy Lewis Cannon
Honoraria - AstraZeneca; Bayer; Deciphera
Consulting or Advisory Role - Intermountain Healthcare
Other Relationship - Navican/ Intermountain Healthcare
 
Anu G. Gaba
Research Funding - Caris Life Sciences (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Tempus (Inst)
 
Walter John Urba
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics (Inst); MedImmune (Inst)
 
Margaret von Mehren
Honoraria - Boehringer Ingelheim; Deciphera; Molleculin
Consulting or Advisory Role - deciphera; GlaxoSmithKline
Research Funding - ASCO (Inst); Deciphera (Inst); Gradalis (Inst); Novartis (Inst); Solaris Health (Inst); Sumitomo Pharma Oncology (Inst); Theseus (Inst)
Patents, Royalties, Other Intellectual Property - cell line
Travel, Accommodations, Expenses - Boehringer Ingelheim
Other Relationship - NCCN
 
Gina N. Grantham
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Honoraria - AVEO; Bristol-Myers Squibb; Janssen; Sanofi
 
Richard L. Schilsky
Leadership - Clarified Precision Medicine; Leap Therapeutics
Stock and Other Ownership Interests - EQRx
Consulting or Advisory Role - Bryologyx; Cellworks; EQRx; Illumina; Scandion Oncology; Syapse; Zephyr AI
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)